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Abstract
Objective: Alterations in blood lipid concentrations in anorexia nervosa (AN) has been reported; 
however, the extent, mechanism, and normalization with weight restoration remain unknown. We 
conducted a systematic review and a meta-analysis to evaluate changes in lipid concentrations in 
acutely-ill AN patients compared with healthy controls (HC) and to examine the effect of partial 
weight restoration.
Method: A systematic literature review and meta-analysis (PROSPERO: CRD42017078014) 
were conducted for original peer-reviewed papers.
Results: Forty-eight studies were eligible for review; 33 for meta-analyses calculating mean 
differences (MD). Total cholesterol (MD = 22.7 mg/dL, 95% CI = 12.5, 33.0), high-density 
lipoprotein (HDL; MD = 3.4 mg/dL, CI = 0.3, 7.0), low-density lipoprotein (LDL; MD = 12.2 
mg/dL, CI = 4.4, 20.1), triglycerides (TG; MD = 8.1 mg/dL, CI = 1.7, 14.5), and apolipoprotein B 
(Apo B; MD = 11.6 mg/dL, CI = 2.3, 21.2) were significantly higher in acutely-ill AN than HC. 
Partially weight-restored AN patients had higher total cholesterol (MD = 14.8 mg/dL, CI = 2.0, 
27.5) and LDL (MD = 19.0 mg/dL, CI = 5.9, 32.0). Pre- versus post-weight restoration differences 
in lipid concentrations did not differ significantly.
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Discussion: We report aggregate evidence for elevated lipid concentrations in acutely-ill AN 
patients compared with HC, some of which persist after partial weight restoration. This could 
signal an underlying adaptation or dysregulation not fully reversed by weight restoration. 
Although concentrations differed between AN and HC, most lipid concentrations remained within 
the reference range and meta-analyses were limited by the number of available studies.
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Introduction
Anorexia nervosa (AN) is characterized by restriction of food intake, and low body mass 
index (BMI). Accompanying symptoms include fear of weight gain, an aversion to foods 
rich in fat and sugar, excessive exercise, distorted body image, and seeming inability to 
recognize the seriousness of the low weight (American Psychiatric American Psychiatric 
Association, 2013). Chronicity is high in AN, and evidence base for effective treatment 
strategies are lacking especially in adults (Bulik, Berkman, Brownley, Sedway, & Lohr, 
2007). Furthermore, AN has one of the highest mortality rates of all psychiatric disorders 
(Chesney, Goodwin, & Fazel, 2014). Therefore, an urgent need exists for improved 
understanding of pathophysiology and etiology of AN to identify effective treatment targets. 
A recent genome-wide association study (GWAS) has identified the first genomic locus 
associated with AN risk, and single nucleotide polymorphism (SNP)-based genetic 
correlations suggest that AN has both psychiatric and metabolic components. More 
specifically, a significant positive genetic correlation between AN and high-density 
lipoprotein (HDL) cholesterol has been reported (Duncan et al., 2017). A second larger 
GWAS has augmented these findings showing significant genetic correlations with 
anthropometric, metabolic, and glycemic traits (Watson, personal communication). 
Likewise, decades of clinical research provide evidence for increased lipid concentrations in 
patients with AN, mirroring the recently-reported significant genetic correlations 
(Klinefelter, 1965).
Although several studies have investigated lipid concentrations in AN, the results have been 
inconsistent as evidence for both increased and decreased lipid concentrations have been 
reported in AN compared with healthy control participants (HC) (Feillet et al., 2000; 
Haluzík et al., 1999a; Haluzík, Papezová, Nedvídková, & Kábrt, 1999b; Shih et al., 2016). 
Most studies published to date had small sample sizes, and only a few investigated 
individuals with AN longitudinally to measure the potential normalization of lipid 
concentrations after weight restoration and/or recovery. Overall, a clear consensus is absent, 
the distinction between state and trait effects is unclear, and the underlying mechanisms 
remain unknown. A normalization of lipid profiles after weight restoration would point 
towards effects of starvation (state effect) whereas similar lipid concentrations before and 
after weight restoration may suggest a more fundamental lipid dysregulation (trait effect) in 
individuals with AN. The differentiation of state and trait is also clinically relevant as it can 
prevent unnecessary aggressive treatment of symptoms which are state-dependent and likely 
to normalize with remission. Based on several guidelines, including the National Cholesterol 
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Education Program (NCEP, 2001), there is no indication for lipid-lowering pharmacological 
treatment in AN due to lipid concentrations, typical age of the patients with AN, their 
predominant gender, their protective HDL levels, and their lack of concomitant 
cardiovascular risk factors (Isner, Roberts, Heymsfield, & Yager, 1985; Matzkin, 
Slobodianik, Pallaro, Bello, & Geissler, 2007).
The investigation of lipid concentrations in AN has the potential to advance our 
understanding of AN and may reveal underlying pathophysiology by determining whether 
the observed alteration in lipid concentrations is a consequence of starvation and/or part of 
the disorder mechanism. Further explication of the role of lipids in AN could potentially 
enhance identification of molecular targets for drug development and improve treatment 
options. Therefore, we systematically reviewed and meta-analyzed case-control studies with 
the aim of critically examining the state of knowledge on lipid concentrations in individuals 
with AN compared with HC before and after partial weight restoration.
Methods
This report was completed in accordance with the Preferred Reporting Items for Systematic 
Review and Meta-Analyses (PRISMA) guidelines (Liberati et al., 2009). Methods of 
analysis and inclusion criteria were specified in advance and documented in a protocol on 
international prospective register of systematic reviews (PROSPERO) with registration 
number: CRD42017078014. The a priori PROSPERO protocol was updated once to match 
the development of the systematic review. All changes and updates are publicly available 
and accepted by PROSPERO. This systematic review has been constructed according to the 
following PICO:
• Population: individuals with AN
• Intervention/indicator: blood tests or other biochemical measures
• Comparison: 1) acutely-ill individuals with AN compared with HC, and 2) AN 
before and after partial weight restoration following treatment
• Outcome: blood lipid profiles
To differentiate between cross-sectional and longitudinal data, we refer to participants at 
baseline measurement as ‘acutely-ill individuals with AN’, and in follow-up studies, the 
participants are referred to as ‘after partial weight restoration’ or ‘partially weight-restored’.
Eligibility criteria
All case-control studies measuring plasma and serum lipid concentrations for all age groups 
in individuals with AN were considered. Acutely-ill individuals and partially weight-
restored individuals compared with HC were investigated. Original peer reviewed papers 
published in English, French, German, Danish, Swedish, and Norwegian were included.
Information sources and search strategy
Five databases (PubMed, Embase, Scopus, PsycInfo, and CINAHL) with the following 
MeSh terms (((anorexia nervosa[MeSH Terms]) OR anorexia nervosa[Title/Abstract])) AND 
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((((lipids[MeSH Terms]) OR lipid[Title/Abstract]) OR cholesterol[MeSH Terms]) OR 
cholesterol[Title/Abstract]).” were searched (Supporting Information: Search strategy). 
Reference lists of key studies were searched manually to retrieve any studies not identified 
in the primary search. No publication date restrictions were imposed. The last search was 
run on 17 February 2017.
Study selection
Covidence was used to assess eligibility in an un-blinded standardized manner by a 
minimum of two reviewers. Title/abstract was screened by AAH, MH, and AMK, full-text 
articles by AAH and MH. Data were extracted by AAH, EL, and CH. Disagreements 
between reviewers were resolved by consensus and/or contact with the authors of the 
studies. The final consensual data extraction sheet was compared to the full-text articles by 
AAH, MH, and CH. Regular supervision and conflict resolution throughout the process was 
provided by JMS.
Data collection process and data items
Covidence was used for data extraction by AAH and EL. Disagreements between data 
extractors were resolved by a third author (JMS) and by re-checking original articles. 
Furthermore, the final data extraction was compared to the original articles by a fourth 
author (MH). Original study authors were contacted for missing data, and additional un-
published author-provided data were obtained. Sample overlap was assessed by juxtaposing 
author names, sample sizes, comparators, and outcomes. A standard data extraction template 
for the systematic review was used (Supporting Information: Standard data extraction 
template).
Risk of bias assessment
To ascertain the validity of eligible studies, pairs of reviewers working independently 
assessed the risk of bias (low/high/unclear) using the Cochrane Collaboration’s risk of bias 
tool (www.handbook.cochrane.org, chapter 8) in individual studies on four domains: 
selection; incomplete outcome data; selective reporting; and other sources. Blinding was, 
initially, included as a fifth domain but none of the included studies reported on this. 
Considering the visibility of extreme underweight in acutely-ill individuals with AN 
blinding of neither patients nor personnel is possible. Therefore, blinding has not been 
included in the risk of bias assessment in the results in (Supporting Information: Risk of 
bias).
We observed potential sample overlap in five studies from the Czech Republic. The authors 
could not rule out data reuse. Therefore, all studies were systematically reviewed, but two 
were excluded from our meta-analysis (Haluzík et al., 1999a; Haluzikova et al., 2009) due to 
a smaller sample size compared with (Krizova et al., 2008) and differing age range with 
(Haluzík et al., 1999b).
Meta-analysis
We performed a meta-analysis in R (version 3.4.3) using the packages ‘metafor’, ‘meta’, and 
‘metasens’. The mean differences (MD) between clinical and control group were the 
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primary effect sizes. A fixed-effect model was deemed inappropriate as significant 
differences were anticipated in procedures and study populations between studies, therefore 
a random-effects model was performed. The random-effects model assumes that the 
heterogeneity in the differences between clinical and control groups is due to two 
components: the within-study and between-study variation explained by clinical and 
methodological differences among the included studies. We used a restricted maximum-
likelihood estimator to calculate heterogeneity. In our meta-analyses, we assumed an 
independent working correlation between longitudinal data points. Missing values (e.g., 
BMI) were calculated if possible. BMI was calculated from average weight and height 
(Castillo, Scheen, Lefebvre, & Luyckx, 1985; Mordasini, Klose, Heuck, Augustin, & 
Greten, 1977). Subgroup analysis of AN subtypes was statistically underpowered (n=10) 
because only one study investigated binge-eating/purging subtype (Case, Lemieux, Kennedy, 
& Lewis, 1999; Sanchez-Muniz, Marcos, & Varela, 1991; Weinbrenner et al., 2004).
After repeated and unsuccessful attempts to contact authors, 15 studies were excluded from 
the meta-analysis (PRISMA) due to missing weight, height, or BMI values (Arden, 
Weiselberg, Nussbaum, Shenker, & Jacobson, 1990; Blickle et al., 1984; Casper, Pandey, 
Jaspan, & Rubenstein, 1988; Crisp, Blendis, & Pawan, 1968; Rigaud, 1999; Stephan, 
Ghandour, Reville, de Laharpe, & Thierry, 1977; Stephan, Schlienger, Blickle, & de 
Laharpe, 1982; Umeki, 1988), implausible results (Miyai, Yamamoto, Azukizawa, Ishibashi, 
& Kumahara, 1975; Ohwada, Hotta, Oikawa, & Takano, 2006; Rigaud, 1999; Terra et al., 
2013), extreme outliers (Case et al., 1999), and potential sample overlap (Haluzík et al., 
1999a; Haluzikova et al., 2009). Additionally, one study (Curatola et al., 2004) reported low-
density lipoprotein (LDL) cholesterol values as a ratio and was therefore excluded.
Publication bias or small study effects
Meta-analysing results from different studies should diminish both bias and uncertainty of 
the overall estimate; however, sometimes this does not hold true as published studies may be 
a biased selection of the evidence (Nieminen, Rucker, Miettunen, Carpenter, & Schumacher, 
2007). To detect potential publication bias, we inspected funnel plots visually (Egger, Davey 
Smith, Schneider, & Minder, 1997) and quantified their asymmetry by statistical tests using 
three different approaches: the Begg and Mazumdar adjusted rank correlation test (Begg & 
Mazumdar, 1994); Egger’s linear regression test (Egger et al., 1997); and a weighted linear 
regression by Thompson and Sharp which allows for between-study heterogeneity 
(Thompson & Sharp, 1999). Significance of these test statistics (p < .05) indicates 
asymmetric funnel plots and suggests publication bias or small study effects. In case of 
suggestive small study effects, we fitted a Copas selection model to adjust our meta-analysis 
for these effects.
Copas selection model
The Copas selection model to correct for potential selection bias comprises two components: 
a model for the meta-analyzed effect and a model estimating the probability that study k is 
selected for publication. The correlation parameter ⍴ between these two components 
indicates the extent of publication bias with larger correlations suggesting more extreme 
effects have been selected for publication (Copas, 1999; Copas & Shi, 2000, 2001). We used 
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the R package ‘metasens’ which fits the Copas selection model repeatedly over a grid of 
tuning parameters γ0 and γ1 and creates a standardised output: a) a funnel plot; b) a contour 
plot; c) a treatment effect plot; and d) a p-value plot.
Meta-regression and stratified subgroup analysis
We detected extensive heterogeneity across the studies. The heterogeneity observed in a 
meta-analysis can be partially systematic and related to clinical study-level variables (i.e., 
moderators), such as age or AN subtype. In secondary analyses, potential moderators were 
therefore explored in stratified subgroup analyses, such as AN subtype, or via meta-
regression analyses, including mean age, the time period of follow-up for longitudinal 
studies, duration of illness, body mass index and its differences between cases and controls. 
Mixed effects models allow for within-study and between-study variation and were therefore 
the most appropriate model indicated by the large heterogeneity estimates detected in our 
primary meta-analyses. We used a restricted maximum-likelihood estimator to calculate the 
heterogeneity included in the R package ‘meta’.
Results
The search identified 765 studies from the following sources: PubMed (283 studies), 
Embase (178 studies), Scopus (224 studies), PsycInfo (57 studies), and CINAHL (21 
studies), and other sources (2 studies). After screening and assessment of abstracts and full 
texts, 48 studies remained. Selection process is described in detail in the PRISMA flow 
diagram (Figure 1).
Lipid concentrations in acutely-ill and partially weight-recovered individuals with AN 
compared with HC
Systematic review—Forty-eight studies of lipid concentrations in individuals with AN 
were included in the systematic review, with a total of 3,037 participants (1,572 individuals 
with AN and 1,465 HC; Table 1). All 48 studies were observational, used a case-control 
design, and has an overall low risk of bias (Figure 2).
Total sample sizes ranged from 12 to 524 participants. Mean age of participants with AN 
and HC ranged from 14.4 to 31.7 years and 15.0 to 50.1 years, respectively. Mean BMI of 
patients with AN and controls ranged from 13.5 to 17.4 kg/m2 and 22.4 to 24.9 kg/m2, 
respectively. Only female participants were included in the studies except for two studies 
(Curatola et al., 2004; Rigaud, Tallonneau, & Verges, 2009) with 83.3% and 96% female 
participants, respectively. Lipid concentrations were comparable across plasma and serum, 
although, different laboratory methods were used. Fasting status reported as ‘overnight’ was 
assumed to last eight hours, and fasting reported in ranges were reported as a mean in Table 
1. The diagnosis of AN was classified according to DSM-5 (American Psychiatric 
Association, 2013) in one study, DSM-IV (American Psychiatric Association, 2000) in 26 
studies, DSM-IV-TR (American Psychiatric Association, 1994) in four studies, DSM-III-R 
(American Psychiatric Association, 1987) in three studies, DSM-III (American Psychiatric 
Association, 1980) in one study, Feighner’s criteria (Feighner et al., 1972) in four studies, 
whereas diagnostic criteria were not specified in the remaining nine studies. In the nine 
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studies with unpecified diagnostic criteria (Blickle et al., 1984; Castillo et al., 1985; Crisp et 
al., 1968; Miyai et al., 1975; Mordasini et al., 1977; Nestel, 1974; Rigaud, 1999; Stephan et 
al., 1977; Uhe et al., 1992), the study participants had low BMIs (<16.3 kg/m2), low 
percentage of ideal body weight (<73.8%), confirmation of the AN diagnosis by psychiatric 
examination, history of food aversion, secondary amenorrhea, and/or rapid weight loss. 
Mean cholesterol concentrations were reported in 41 studies, HDL in 28 studies, LDL in 26 
studies, very low-density lipoprotein (VLDL) cholesterol in five studies, triglycerides (TG) 
in 32 studies, free fatty acids (FFA) in 14 studies, (apolipoprotein a1) Apo a1 in nine studies, 
and (apolipoprotein B) Apo B in 12 studies (Table 1 and 2).
Meta-analysis—In addition to the systematic review, we also performed separate meta-
analyses for total cholesterol, HDL, LDL, VLDL, TG, FFA, Apo a1, and Apo B 
concentrations to compare: (1) either acutely-ill or partially weight-restored individuals with 
AN with HC; and (2) AN patients before and after partial weight restoration (Table 3).
A random-effects meta-analysis revealed a statistically significant positive mean difference 
(MD) for total cholesterol (MD = 22.7 mg/dL, 95% CI = 12.5, 33.0; p < .0001 ; Figure 3), 
HDL (MD = 3.4 mg/dL, 95% CI = 0.30, 6.95; p = .03), LDL (MD = 12.2 mg/dL, 95% CI = 
4.4, 20.1; p = .002), TG (MD = 8.1 mg/dL, 95% CI = 1.7, 14.5; p = .014), and Apo B (MD = 
11.8 mg/dL, 95% CI = 2.2, 21.2; p = .02) comparing acutely-ill individuals with AN with 
HC. In summary, we found evidence for significantly higher lipid concentrations in 
individuals with AN compared with HC. Forest plots for all outcomes are presented in 
Supporting Information (Figures S1–S7). As only one study (Sanchez-Muniz et al., 1991) 
investigated the binge-eating/purging subtype of AN, the subgroup analysis therefore was 
limited (Supporting Information Figure S8). The subtype analysis examining the different 
diagnostic criteria for AN showed that studies not reporting any diagnostic criteria found 
large mean differences compared with the rest (Supporting Information Figure S9). These 
subgroup analyses showed a significant difference between diagnostic criteria (p<.0001), but 
not between the different subtypes (p=0.27). All results from the subgroup analyses of 
subtype and diagnostic criteria are presented for acutely-ill/pre-treatment AN compared with 
HC (Supporting Information Table S1).
Heterogeneity across studies was statistically significant for every outcome (Table 3). Visual 
inspection of the funnel plots for each outcome suggested some asymmetry. We fitted a 
Copas selection model for the pre-treatment total cholesterol meta-analysis between acutely-
ill individuals AN and HC because small study effects were indicated by a significant 
Thompson and Sharp test (p = .008). The Copas selection model analysis did not overturn 
the conclusion of the original meta-analysis, although, the adjusted estimate of 14.0 mg/dL 
(95% CI = 6.8, 21.2; p < .0001 ) with an estimated selection probability of 59% and 13 
potentially unpublished studies is about half of the random effects model estimate with 22.7 
mg/dL (95% CI = 12.5, 33.0) (Supporting Information Figure S10a–d).
We then conducted a meta-regression to examine the association of the proposed 
moderators, BMI, the difference in BMI between cases and controls, age of individuals with 
AN, fasting period, duration of illness, and duration of follow-up with the MDs in lipid 
concentrations (Supporting Information Figures S11–S22). The results from the meta-
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regression for the acutely-ill individuals with AN compared with HC are reported in Table 4. 
Additional results are reported in Supporting Information Table S2 & S3.
Our analyses revealed a significant positive association of HDL with BMI (β = 2.7, 95% CI 
= 0.5, 5.0; p = .02, Figure 4) in acutely-ill AN patients. Our analyses also showed a 
significant negative association of VLDL with BMI (β = −5.8, 95% CI = 8.34, 3.2; p < .01; 
Supporting Information Figure S11), however, only three studies on VLDL were eligible for 
inclusion in the meta-regression analysis, rendering our analysis exploratory in nature. None 
of the other outcomes showed significant associations with BMI. Our analyses also revealed 
a significant positive association with TG for mean disease duration (β = 0.02; 95% CI = 
0.01, 0.02; p < 0.01; Supporting Information Figure S13) and fasting duration (β = 3.5; 95% 
CI = 0.6, 6.5; p = 0.02). Although, 18 studies contributed to the meta-regression of TG on 
fasting duration, this analysis must be interpreted cautiously as the majority of the data 
points are accumulated by the fact that we assumed on average an eight-hour period for 
overnight fasting (Supporting Information Figure S14).
Following partial weight restoration, total cholesterol (MD = 14.8 mg/dL, 95% CI = 2.0, 
27.5; p = .02; Supporting Information Figure S23) and LDL (MD = 19.0 mg/dL, 95% CI = 
5.9, 32.0; p = .005; Supporting Information Figure S25) were still significantly higher in 
individuals with AN when compared with HC. Meta-analyses for VLDL (k = 1), FFA (k = 
1), Apo a1 (k = 0), and Apo B (k = 0) could not be carried out due to limited number of 
studies. Heterogeneity was significant for total cholesterol, LDL, and TG, but not for HDL 
(Table 3). None of the formal tests for funnel plot asymmetry were significant, indicating no 
small study effects (Supporting Information Table S4), and no meta-regression was 
significant for any of the lipids (Supporting Information Table S2 & S3.
We also performed a subgroup analysis of studies assessing LDL concentrations measured in 
assays only. The results still show significantly increased LDL concentrations in acutely-ill 
patients with AN compared to HC (MD = 25.1 mg/dL, 95% CI = 5.2, 45.0; p = .013), 
partially weight-restored patients with AN compared with HC (MD = 28.4 mg/dL, 95% CI = 
15.3, 41.6; p < .0001), and no significant difference when estimating the change of LDL 
concentrations between partially weight-restored AN and acutely-ill AN (MD = −12.4 
mg/dL, 95% CI = −35.4; 10.5; p = .29). No meta-regression for the proposed moderators 
was significant.
Lipid concentrations before and after partial weight restoration in individuals with AN
Systematic review—Out of the 48 study included, 17 studies (marked with ‘X’ in Table 
1) also described lipid profiles in AN before and after partial weight restoration compared 
with HC. Participants in the groups undergoing weight restoration were followed-up at 
different timepoints (e.g., 6-week follow-up, 1-year follow-up, weight-recovered AN, and 
recovered AN). We summarized those by using the term ‘after partial weight restoration’ 
(Methods). Of the 17 weight restoration studies, there was no significant difference in lipid 
concentrations in eight (47%) of the studies (Crisp et al., 1968; Haluzík et al., 1999b; 
Heilbronn, Milner, Kriketos, Russell, & Campbell, 2007; Kavalkova et al., 2012; Misra et 
al., 2006; Shih et al., 2016; Umeki, 1988; Uzum, Yucel, Omer, Issever, & Ozbey, 2009). One 
of 17 (6%) studies reported that the lipid profile normalized after weight gain but numerical 
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values were not available (Rigaud et al., 2009). Three of 17 (18%) studies reported 
significantly increased HDL concentrations after weight gain (Arden et al., 1990; Matzkin et 
al., 2007; Nova, Lopez-Vidriero, Varela, Casas, & Marcos, 2008), while one study (6%) 
reported significantly decreased HDL concentrations (Rigaud, 1999). Three of 17 (18%) 
studies also found significantly decreased total cholesterol concentrations after weight gain 
(Lejoyeux et al., 1996; Mordasini et al., 1977; Ohwada et al., 2006). Furthermore, 
significantly decreased LDL concentrations (Rigaud, 1999), significantly decreased TG 
concentrations (Arden et al., 1990), and significantly increased FFA concentrations (Casper 
et al., 1988) were found after weight gain treatment in one study each. The review of the 
literature identified nine additional studies that did not meet the inclusion criteria of 
comparison to a HC, but due to the longitudinal study design they were included in an 
additional comparative analysis (Supporting Information, Table S5).
Meta-analysis—Meta-analyses were performed for total cholesterol, HDL, LDL, and TG 
concentrations in individuals with AN before and after partial weight restoration, showing 
no significant changes in lipid concentrations (Table 3). Meta-analyses for VLDL (k = 1), 
FFA (k = 1), Apo a1 (k = 0), and Apo B (k = 0) could not be carried out due to the limited 
number of studies. The forest plots are available in Supporting Information (Figure S27–
S30).
Discussion
This systematic review identified 48 studies and found evidence of increased lipid 
concentrations in individuals with AN during the rapid weight loss phase (acutely-ill AN) 
compared with HC. Furthermore, some of the increases in lipid concentrations persisted 
after partial weight restoration. A meta-analysis was carried out for 33 eligible studies and 
showed significantly increased concentrations of total cholesterol, HDL, LDL, and TG in 
acutely-ill individuals with AN compared with HC, and also significantly increased 
concentrations of total cholesterol and LDL in partially weight-recovered individuals with 
AN when compared with HC. No significant differences in lipid concentrations were found 
in our longitudinal meta-analyses investigating the changes in lipid concentrations in 
individuals with AN before and after partial weight restoration.
Only the meta-analysis of total cholesterol comparing acutely-ill individuals with AN with 
HC showed small study effects (e.g., selection bias); however, the adjusted estimate still 
indicated a significant difference between individuals with AN and HC. The subgroup 
analyses for AN subtypes pre-treatment was not significant. However, we were unable to 
meaningfully investigate differences between restricting and binge-eating subtype as only 
one study sampled participants with the binge-eating/purging subtype. The post-hoc meta-
regression found a positive significant association of BMI in acutely-ill individuals with AN 
and HDL. Higher BMI was associated with a larger MD in HDL in individuals with AN, 
which is interesting considering recent findings of a positive genetic correlation of HDL 
cholesterol with AN (Duncan et al., 2017). Additionally, a negative significant association 
was found between BMI in acutely-ill individuals with AN and VLDL, but due to the small 
number of studies included (k = 3), this result is exploratory and must be interpretated with 
caution.
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Potential mechanisms behind increased lipid concentrations in individuals with AN have 
been discussed and suggested in several studies. Since lipid metabolism is complex, the 
increased lipid concentrations found in AN may be the consequence of multiple causes. For 
example, it has been proposed that excessive alimentary intake in individuals of AN (i.e., 
binge-eating/purging AN subtype) may increase lipid concentrations (Feillet et al., 2000). 
However, the diet of individuals with AN is typically low in total fats (Allen et al., 2013), 
and therefore unlikely to explain the observed increase in lipid concentrations, although, low 
dietary lipid intake does not exclude increased absorption. Furthermore, some studies 
suggest increased absorption of exogenous cholesterol indicated by higher concentrations of 
the phytosterols campesterol and beta-sitosterol—steroids derived from plants— in 
individuals with AN (Zák et al., 2005; Zák et al., 2003), and potentially, these changes in 
absorption may be influenced by alterations in gut microbiota (Glenny, Bulik-Sullivan, Tang, 
Bulik, & Carroll, 2017; Schwensen, Kan, Treasure, Hoiby, & Sjogren, 2018). Increased 
endogenous cholesterol synthesis seems to be unlikely in individuals suffering from AN 
(Feillet et al., 2000; Weinbrenner et al., 2004; Zák et al., 2005; Zák et al., 2003).
Another potential mechanism is the interaction between lipids and hormones. Lipid 
concentrations are tightly regulated by hormones and very low lipid intake and low energy 
diet—which is common in AN—can induce hypoinsulinemia, increase insulin sensitivity, 
and in severe cases may lead to hypoglycaemia. Adipose tissue plays an important role in 
the regulation of insulin sensitivity, and cross-talk between glucose and lipid metabolism 
occurs (Saltiel & Kahn, 2001). Additionally, stress increases epinephrine, cortisol, growth 
hormone (GH), and glucagon, and has been observed in combination with low 
triiodothyronine (T3) concentrations in AN (Schorr & Miller, 2017). Associations between 
low T3 and Apo B, HDL, and LDL concentrations may be mediated by the cholesterol ester 
transfer protein (CETP) in the human liver. It shows significantly higher activity in AN 
compared with HC (Ohwada et al., 2006). However, high T3 (Rigaud et al., 2009; 
Weinbrenner et al., 2004; Zák et al., 2005) and low T3 (Matzkin, Geissler, Coniglio, Selles, 
& Bello, 2006) have been associated with increased HDL, but one study showed no 
association (Ohwada et al., 2006), rendering results inconclusive. Furthermore, GH is 
elevated in AN (Schorr & Miller, 2017) and may have a direct lipolytic effect independent 
from insulin-like growth factor 1 (IGF-1), increasing especially LDL concentrations (Misra 
et al., 2006).Another potential explanation is that steroid hormones such as cortisol and 
estradiol (for which cholesterol is the precursor) are associated with lipid alterations and, in 
AN the hypoestrogenic state is differentially associated with increased cholesterol in 
premenarchal and postmenarchal female patients (Swenne, 2016). Endothelial dysfunction 
and hyperlipdemia along with menstrual disturbances in association with estrogen status 
have also been reported (Rickenlund, Eriksson, Schenck-Gustafsson, & Hirschberg, 2005).
Several studies have raised the question whether increased lipid concentrations during the 
rapid weight loss phase of AN is specifically related to the disorder or merely reflect the 
hypocaloric starvation state. In a small study (n=16) on the effect of complete food 
deprivation for in endurance-trained healthy men who engaged in 10 hours of physical 
activity per day, the participants had decreased concentrations of LDL and TG alongside 
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increased concentrations of total cholesterol, HDL, and FFA as they entered a catabolic 
process and lost weight over an 81-hour period; however, all of these changes were reversed 
within 12 days of recovery, showing a normalization of lipid concentrations (Shpilberg et al., 
1990). These results contradict our findings, where we found that individuals with AN do 
not seem to reach lipid concentrations comparable with HC after partial weight restoration, 
supporting the notion of an underlying dysregulation.
In longitudinal studies of individuals with AN where lipid profiles normalize after weight 
restoration, the evidence points towards the effects of starvation for the reason behind the 
increased lipid concentrations (Rigaud et al., 2009), whereas studies in which there are no 
significant differences before and after weight restoration may suggest a more fundamental 
lipid dysregulation (Crisp et al., 1968; Haluzík et al., 1999b; Heilbronn et al., 2007; 
Kavalkova et al., 2012; Misra et al., 2006; Shih et al., 2016; Umeki, 1988; Uzum et al., 
2009).
One association observed in our meta-analysis seems paradoxical as higher HDL cholesterol 
was associated with increasing BMI in acutely-ill individuals with AN. This phenomenon 
has been previously reported (Mehler, Lezotte, & Eckel, 1998; Weinbrenner et al., 2004) and 
remains an enigma. Emerging evidence by Duncan et al. (Duncan et al., 2017), however, 
showed a significant positive genetic correlation between AN and HDL cholesterol, 
suggesting that increased lipid concentrations in AN cannot solely be explained by the effect 
of starvation but more probably by a shared genetic underpinning. Future studies will need 
to elucidate the mechanisms underlying the increased lipids seen in AN.
Implications for future research
By standardizing study designs and measures, it is possible to obtain meaningful, replicable, 
and interpretable results. Prospective controlled studies examining the lipid profiles before, 
during, and after weight gain in large samples of well-characterized patients with long-term 
follow-up are warranted to understand effects of starvation and underlying biology. 
Additionally, repeated lipidomic profiles in combination with detailed anthropometrics could 
help in understanding the mechanism behind potential lipid alterations and may elucidate 
whether increased lipid concentrations in AN are state- or trait-related. It is important to 
determine how long the effects of starvation prevail to potentially identify subgroups in AN 
with persistently higher lipid profiles beyond the point of complete recovery.
The differentiation of state and trait is relevant as it can identify symptoms which are state-
dependent in individuals with AN and likely to normalize with remission. If increased lipid 
concentrations are caused by starvation, they will be correctable by refeeding and weight 
restoration. However, if increased lipid concentrations are caused by an underlying lipid 
dysregulation predating the emergence of AN, further in-depth examinations would be 
warranted to to clarify the cause and site of dysregulation. Lipidomics (full characterization 
of lipid molecular species and of their biological roles) could assist in understanding the 
mechanism behind a potential lipid dysregulation (Wenk, 2010).
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The Cohen’s Kappa/inter-reviewer reliability coefficient for the study selection process 
could not be calculated as Covidence does not retain information on a reference or study’s 
voting history once it moves from one task to the next in the screening process. To be able to 
calculate the inter-reviewer reliability coefficient the number of conflicts in the Resolve 
Conflicts page should be checked following each stage of screening and these data are not 
available any longer in Covidence.
AN sample included in the systematic review and meta-analysis was very heterogenous in 
regards to illness duration and severity, diagnostic tools used to assess AN (including studies 
using varying diagnostic criteria for AN and overlap between DSM-IV and DSM-5), BMI, 
body fat mass, age, sex, different fasting periods before blood withdrawal, and lipid 
concentrations measured in both plasma and serum with different analytical methods 
(Beheshti, Wessels, & Eckfeldt, 1994), all of which add to the risk of bias. Furthermore, 
only one study investigated AN binge-eating/purging subtype (Case et al., 1999; Sanchez-
Muniz et al., 1991; Weinbrenner et al., 2004), subtype analyses were not feasible due to lack 
of statistical power.
Most of these observations are only correlational and have been investigated in very small 
sample sizes with limited statistical power. Studies with larger sample sizes and replication 
of these findings with in-depth investigations are needed to confirm the validity of these 
results.
Conclusion
In this systematic review and meta-analysis, we find evidence of 1) elevated lipid and 
lipoprotein concentrations in individuals with AN compared with HC; and 2) persistence of 
elevated lipid concentrations in AN after partial weight restoration. The elevated lipid and 
lipoprotein concentrations alone could be effects of starvation, yet in the longitudinal studies 
with the persistenly elevated lipid concentrations the evidence points towards a more 
fundamental lipid dysregulation which could be presents only in a subgroup of individuals 
with AN.
Our results also show increased HDL cholesterol concentrations were associated with BMI 
in acutely-ill individuals with AN, which mirrors the positive genetic correlation between 
HDL cholesterol and AN uncovered by AN GWAS (Duncan et al., 2017). Our phenotypic 
finding in combination with the genetic component should be followed up in larger 
longitudinal studies to investigate if the persistently elevated lipid levels are merely effects 
of starvation (state-related) or actually due to an underlying dysregulation in the lipid 
metabolism (trait-related) in individuals with AN.
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Refer to Web version on PubMed Central for supplementary material.
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Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow 
diagram of study selection process. PICO: population, intervention, comparator and 
outcomes. BMI: body mass index.
Hussain et al. Page 18














Percent of studies exhibiting degrees of bias. Included studies were assessed for risk of bias 
using the Cochrane Collaboration’s risk of bias tool focused on four domains. Each item was 
rated with ‘high’, ‘low’ or ‘unclear’ risk of bias.
Hussain et al. Page 19














Forest plot for total cholesterol concentrations in acutely-ill individuals with anorexia 
nervosa (AN) compared with healthy control participants. SD: standard deviation. MD: 
mean difference. CI: confidence interval.
Hussain et al. Page 20














Bubble plot. Meta-regression examining the association of the moderator BMI with the 
mean differences in high-density lipoprotein (HDL) cholesterol between acutely-ill 
individuals with anorexia nervosa and healthy control participants. Bubble size is inversely 
proportional to the variance of the estimated mean difference. This means bubbles are sized 
according to the precision of each estimate with larger bubble for more precise estimates.
Hussain et al. Page 21
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